What is the ticker symbol for Apollomics?

Apollomics trades under the ticker APLM on NASDAQ.

What sector does Apollomics operate in?

Apollomics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze APLM in a portfolio?

PortView shows APLM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Apollomics (APLM) Stock Analysis

NASDAQHealthcareBiotechnology

$27.37+1.60%

1-year price historyRange $4.19 – $36.65

52-week range$27.37

$3.95$42.12

What Apollomics does

Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.

Key metrics

Market cap

$60.11M

P/E (TTM)

-3.62

EPS (TTM)

$-7.57

Beta

1.45

Dividend yield

0.00%

Revenue / share

$20.19

50-day avg

$20.29

200-day avg

$17.92

52-week high

$42.12

52-week low

$3.95

CEO

Hung-Wen Chen

ETFs linked to APLM

Broad-market and Healthcare sector ETFs an investor holding Apollomics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how APLM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze APLM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Apollomics?: Apollomics trades under the ticker APLM on NASDAQ.
Which exchange is APLM listed on?: APLM is listed on NASDAQ.
What sector does Apollomics operate in?: Apollomics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze APLM in a portfolio?: PortView shows APLM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.